Outlook Therapeutics to Present Pivotal Data from NORSE TWO Trial at the 9th International Congress on OCT and OCT Angiography in Rome (ICOOR)/ FLORetina Symposia
Francesco Bandello, MD, FEBO, will present Phase 3 pivotal safety and efficacy data from the…
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth
Central Asia visit drives multi-sector collaboration, Business delegation signed 66 MoUs and agreements to seize Belt and Road opportunities
Custom Health Holdings Inc. Announces Completion of Plan of Arrangement
Hyper Bit Technologies Announces Director Resignation and Provides Corporate Update
iFabric Corp. Announces Closing of $28 Million Bought Deal Offering